Day: May 17, 2025

New publication in npj Precision Oncology demonstrates VAR2CSA’s utility as a tumor-agnostic, platform-independent circulating tumor cell liquid biopsy platform

Circulating tumor cells (CTCs) – cancer cells shed from tumors to the bloodstream – are some of the most studied liquid cancer biomarkers and offer enormous predictive and prognostic potential. But their rarity and heterogeneity as resulted in a plethora of isolation and detection methods aiming to expand their clinical utility. In a collaboration with […]